Exercise-based Motivational Interviewing for Fibromyalgia
Fibromyalgia
About this trial
This is an interventional supportive care trial for Fibromyalgia focused on measuring Fibromyalgia, Fibromyalgia patients
Eligibility Criteria
Inclusion Criteria:
- American College of Rheumatology (ACR) classification criteria for FMS(203)
- Has been on stable doses of FMS medications (i.e., cyclobenzaprine, tramadol, gabapentin, pregabalin, venlafaxine, duloxetine, pramipexole, tricyclic anti-depressant, selective serotonin reuptake inhibitor) for at least 4 weeks and willing to limit the introduction of new medications for FMS symptoms
- Age between 18-65 years old. Because the prevalence of sub-clinical coronary artery disease increases with older age, we are excluding those who are ≥ 66 years old
Exclusion Criteria:
- FIQ-PI score < 2
- BPI-PS <4
- Known cardiovascular disease, including congestive heart failure; previous episodes of angina pectoris; previous myocardial infarction; or previous revascularization procedure
- Moderate-severe chronic obstructive pulmonary disease, including asthma
- Uncontrolled hypertension
- Orthopedic or musculoskeletal conditions that would prohibit moderate-intensity exercise
- Active suicidal ideation
- Planned elective surgery during the study period
- Ongoing unresolved disability claims
- Other major rheumatic conditions (i.e. rheumatoid arthritis, systemic lupus erythematosus, scleroderma and other connective tissue disease)
- Use of medications that may affect chronotropic response to exercise, i.e. beta-blocker or calcium channel blocker
- Pregnancy
- Schizophrenia or other psychosis
- Exercising 3 days a week or more. The US Surgeon General considers a physically active person as somebody who does at least 3 times a week of moderate to vigorous level of exercise(204). Thus, we are excluding the already physically active individuals from the study. In the pilot study, only 4% (2 out of 50) of the potential participants were excluded due to being physically active.
Sites / Locations
- National Institute of Fitness of Sports, IUPUI Campus
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
1
2
Telephone Call for the Attention Control Group Each AC call will follow the same format as the MI call. During the AC call, study subjects will receive health information on important topics relevant to their illness. Specifically, there will be one topic during each phone call that includes the following: (a) overview of FMS, (b) pain, (c) fatigue (d) sleep, (e) stress, and (f) living well with FMS. The AC calls will be an avenue to transfer relevant health information from the RA to the study subject. The scheduled topics during each contact will give the call face validity (i.e., establish a credible pretense for the contact) while being neutral with respect to encouragement of exercise.
Telephone-delivered Motivational Interviewing Participants will receive 6 telephone calls throughout the study. Harland et al reported that the most effective intervention for promoting exercise in the primary care setting was the most intensive treatment arm that included six MI sessions (208). Importantly, in our pilot study, participants who completed 5 to 6 phone calls achieved greater symptomatic benefits than participants who had ≤ 4 phone calls. The phone calls will be scheduled at week 3, 4, 6, 8, 10 and 12 of the study. Telephone sessions may run for 30 minutes on the average